Diabetes and Prediabetes in Children With Cystic Fibrosis: A Systematic Review of the Literature and Recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED).

abnormal glucose tolerance continuous glucose monitoring cystic fibrosis-related diabetes glargine insulin oral glucose tolerance test (OGTT) prediabetes recommendations systematic review

Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2021
Historique:
received: 27 02 2021
accepted: 29 03 2021
entrez: 21 5 2021
pubmed: 22 5 2021
medline: 21 12 2021
Statut: epublish

Résumé

Cystic fibrosis related diabetes (CFRD) is a comorbidity of cystic fibrosis (CF) that negatively impacts on its clinical course. Prediabetes is an important predictor of either CFRD development and unfavorable prognosis of CF in both pediatric and adult patients. International guidelines recommend insulin only in case of CFRD diagnosis. Whether early detection and treatment of prediabetes may contribute to improve the clinical course of CF is still debated. A subgroup of pediatric diabetologists of the Italian Society for Pediatric Endocrinology and Diabetology (ISPED) performed a systematic review of the literature based on predefined outcomes: impact of pre-diabetes on clinical outcomes and on the risk of developing CFRD; diagnosis of diabetes and pre-diabetes under 10 years of age; effectiveness of therapy on glycemic control, impact of therapy on pulmonary function and nutritional status. Thirty-one papers were selected for the analysis data presented in these papers were reported in tables sorted by outcomes, including comprehensive evidence grading according to the GRADE approach. Following the grading of the quality of the evidence, the entire ISPED diabetes study group achieved consensus for the Italian recommendations based on both evidence and clinical experience. We concluded that in patients with CF, prediabetes should be carefully considered as it can evolve into CFRD. In patients with CF and prediabetic conditions, after complete evaluation of the OGTT trend, glucometrics, glycemic values measured during pulmonary exacerbations and/or steroid therapy, early initiation of insulin therapy could have beneficial effects on clinical outcomes of patients with CF and prediabetes.

Identifiants

pubmed: 34017312
doi: 10.3389/fendo.2021.673539
pmc: PMC8130616
doi:

Substances chimiques

Blood Glucose 0
Hypoglycemic Agents 0
Insulin 0

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

673539

Informations de copyright

Copyright © 2021 Mozzillo, Franceschi, Piona, Passanisi, Casertano, Pjetraj, Maltoni, Calcaterra, Cauvin, Cherubini, D’Annunzio, Franzese, Frongia, Lombardo, Lo Presti, Matteoli, Piccinno, Predieri, Rabbone, Scaramuzza, Toni, Zucchini, Maffeis and Schiaffini.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Diabetes Care. 2009 Sep;32(9):1626-31
pubmed: 19542209
J Clin Endocrinol Metab. 2020 Jul 1;105(7):
pubmed: 32232400
J Cyst Fibros. 2014 Jan;13(1):80-5
pubmed: 23809507
Eur Respir J. 2005 Apr;25(4):715-7
pubmed: 15802348
J Clin Endocrinol Metab. 2021 Mar 25;106(4):e1793-e1802
pubmed: 33331877
Diabetes Obes Metab. 2019 Mar;21(3):700-704
pubmed: 30259623
Eur J Clin Microbiol Infect Dis. 2016 Jun;35(6):947-53
pubmed: 26993289
Arch Dis Child. 2012 May;97(5):464-7
pubmed: 21493664
Diabet Med. 2019 Oct;36(10):1251-1255
pubmed: 30697808
Diabetes Care. 2010 Feb;33(2):311-6
pubmed: 19918014
J Cyst Fibros. 2009 May;8(3):174-8
pubmed: 19162566
Diabetes Care. 2012 Nov;35(11):e78
pubmed: 23093689
Nutr Metab Cardiovasc Dis. 2021 Jan 4;31(1):277-285
pubmed: 32981797
J Cyst Fibros. 2008 Mar;7(2):134-6
pubmed: 17692577
J Cyst Fibros. 2021 Mar;20(2):339-345
pubmed: 32928701
J Cyst Fibros. 2016 Jan;15(1):127-32
pubmed: 25818059
J Clin Epidemiol. 2013 Jul;66(7):719-25
pubmed: 23312392
J Pediatr Endocrinol Metab. 2018 Oct 25;31(10):1139-1146
pubmed: 30244233
Pediatr Diabetes. 2009 May;10(3):162-7
pubmed: 19207231
Lancet Diabetes Endocrinol. 2018 Feb;6(2):114-121
pubmed: 29199116
Arch Med Sci. 2016 Apr 1;12(2):402-7
pubmed: 27186187
Diabetes Res Clin Pract. 2015 Dec;110(3):276-84
pubmed: 26508676
J Cyst Fibros. 2020 Sep;19(5):700-703
pubmed: 32111453
J Cyst Fibros. 2021 Jan 18;:
pubmed: 33478894
PLoS One. 2015 Mar 24;10(3):e0119938
pubmed: 25803537
Diabetes Ther. 2017 Oct;8(5):1187-1190
pubmed: 28770464
J Cyst Fibros. 2014 Jul;13(4):478-84
pubmed: 24359972
Pediatr Diabetes. 2018 Oct;19 Suppl 27:64-74
pubmed: 30094886
Am J Respir Crit Care Med. 2016 Oct 15;194(8):974-980
pubmed: 27447840
Diabetes Care. 2009 Oct;32(10):1783-8
pubmed: 19592632
J Cyst Fibros. 2020 Mar;19(2):305-309
pubmed: 31126898
Pediatr Pulmonol. 2015 Feb;50(2):144-9
pubmed: 24678051
Pediatr Diabetes. 2010 Nov;11(7):487-92
pubmed: 20202149
J Cyst Fibros. 2019 Nov;18(6):869-873
pubmed: 31036487
Chest. 2007 Aug;132(2):562-8
pubmed: 17646236
J Pediatr Endocrinol Metab. 2017 Aug 28;30(8):815-821
pubmed: 28245190
Eur J Endocrinol. 2010 Apr;162(4):705-10
pubmed: 20071479
BMC Pulm Med. 2017 Apr 21;17(1):70
pubmed: 28431569
J Cyst Fibros. 2018 Nov;17(6):798-803
pubmed: 29885744
J Pediatr Endocrinol Metab. 2011;24(7-8):449-54
pubmed: 21932580
Pediatr Diabetes. 2012 Mar;13(2):197-202
pubmed: 22060105
Acta Paediatr. 2001 Aug;90(8):860-7
pubmed: 11529531
Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):891-5
pubmed: 10988101
J Clin Epidemiol. 2011 Apr;64(4):383-94
pubmed: 21195583
Cochrane Database Syst Rev. 2020 Oct 19;10:CD004730
pubmed: 33075159
Pediatr Pulmonol. 2015 Oct;50(10):963-9
pubmed: 26087115

Auteurs

Enza Mozzillo (E)

Department of Translational Medical Science, Section of Pediatrics, Regional Center of Pediatric Diabetes, Federico II University of Naples, Naples, Italy.

Roberto Franceschi (R)

Pediatric Unit, S. Chiara Hospital, Trento, Italy.

Claudia Piona (C)

Regional Center for Pediatric Diabetes, University of Verona, Verona, Italy.

Stefano Passanisi (S)

Department of Human Pathology in Adult and Developmental Age, University of Messina, Messina, Italy.

Alberto Casertano (A)

Department of Translational Medical Science, Section of Pediatrics, Regional Center of Pediatric Diabetes, Federico II University of Naples, Naples, Italy.

Dorina Pjetraj (D)

SOD Pediatric Diabetology, Department of Women's and Children's, "G. Salesi" Children's Hospital, AOU Ospedali Riuniti, Ancona, Italy.

Giulio Maltoni (G)

Department of Woman, Child and Urological Diseases, S. Orsola-Malpighi University Hospital, Bologna, Italy.

Valeria Calcaterra (V)

University of Pavia, Pavia and Department of Pediatrics, "Vittore Buzzi" Children's Hospital, Milano, Italy.

Vittoria Cauvin (V)

Pediatric Unit, S. Chiara Hospital, Trento, Italy.

Valentino Cherubini (V)

SOD Pediatric Diabetology, Department of Women's and Children's, "G. Salesi" Children's Hospital, AOU Ospedali Riuniti, Ancona, Italy.

Giuseppe D'Annunzio (G)

IRCCS Istituto Giannina Gaslini, Genova, Italy.

Adriana Franzese (A)

Department of Translational Medical Science, Section of Pediatrics, Regional Center of Pediatric Diabetes, Federico II University of Naples, Naples, Italy.

Anna Paola Frongia (AP)

Diabetes Unit, Ospedale Brotzu, Cagliari, Italy.

Fortunato Lombardo (F)

Department of Human Pathology in Adult and Developmental Age, University of Messina, Messina, Italy.

Donatella Lo Presti (D)

Centro di Riferimento Regionale di Diabetologia Pediatrica A.O.U. Policlinico G. Rodolico, Catania, Italy.

Maria Cristina Matteoli (MC)

Diabetes Unit, Bambino Gesù Children's Hospital, Rome, Italy.

Elvira Piccinno (E)

D.A.I. Pediatria, Ospedale Pediatrico Giovanni XXIII, Bari, Italy.

Barbara Predieri (B)

Department of Medical and Surgical Sciences of the Mother, Children and Adults - Pediatric Unit, University of Modena and Reggio Emilia, Modena, Italy.

Ivana Rabbone (I)

Division of Pediatrics, Department of Health Science, University of Piemonte Orientale, Novara, Italy.

Andrea Enzo Scaramuzza (AE)

Diabetes & Nutrition Unit, Pediatrics, ASST Cremona, Cremona, Italy.

Sonia Toni (S)

Pediatric Diabetology Unit, Meyer Children Hospital, Florence, Italy.

Stefano Zucchini (S)

Department of Woman, Child and Urological Diseases, S. Orsola-Malpighi University Hospital, Bologna, Italy.

Claudio Maffeis (C)

Regional Center for Pediatric Diabetes, University of Verona, Verona, Italy.

Riccardo Schiaffini (R)

Diabetes Unit, Bambino Gesù Children's Hospital, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH